🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brooke Augustine

National Cancer Institute

ORCID: 0000-0001-7932-1517
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial”.

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

The Lancet(2023)10.1016/s0140-6736(22)02400-x
N/A
4.3DataRank · unranked
65 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Christine Lee, Anne Preston +50 more

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2145
N/A
0.416DataRank · unranked
15 citations

Naoko Takebe, Shivaani Kummar, Albiruni R. Abdul Razak, Sant P. Chawla, Suzanne George +13 more

Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013252
N/A
0DataRank · unranked
1 citations

Geraldine O’Sullivan Coyne, Larry Rubinstein, Sarah J Shin, Naoko Takebe, Ashley Bruns +12 more

Phase 2 evaluation of the nilotinib-paclitaxel combination in patients with rare solid tumors: Rapid analysis and response evaluation of combination anti-neoplastic agents in rare tumors trial 1 (RARE CANCER 1).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.3015
N/A
0DataRank · unranked
0 citations

Andre DeSouza, Jared C. Foster, Naoko Takebe, Geraldine O’Sullivan Coyne, Sarah Miller +8 more